The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths forward.
Providence Swedish is harnessing the power of "big data" in medicine to accelerate biomedical research. Learn more.
New research from Providence suggests that a specialized training for frontline clinicians could help address drivers of healthcare workforce burnout.
An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.
After facing a life-altering brain tumor, this Providence Swedish patient discovered clarity, gratitude, and a mission to support the research that guided her care.
An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.
A new oral therapy is available for metastatic pancreatic cancer that has progressed after chemotherapy.
When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.
For patients living with autoimmune diseases, every day can be a challenge. But now, a research breakthrough using CAR T cellular therapy could change the story.
A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.
Providence Cancer Institute is connecting patients with new possibilities for care — often close to home — through innovative clinical trials.
A July 2026 news story in the publication Catholic Health World highlights Providence’s participation in a groundbreaking research project aimed at helping predict mental health crises.
Learn how the Providence Montana Heart Institute is working to bring world-class clinical research and the latest heart care and treatment options closer to Montana communities.
New radiation safety research from Providence CARDS and Providence Heart Institute of Oreogn could help bring more women into interventional cardiology
PSNI collaborates with Seattle-based HDT Bio on preparations for trialing novel treatment to breach blood-brain barrier
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
Based on research around the innovative Hawk's Eye Apartments project in Clatsop County, Oregon, Providence CORE offers five key takeaways for healthcare investments in affordable workforce housing.
Providence researchers conducted over 1500 studies in 2025, according to a new report from the Providence Research Network. Check out the 2025 research program brief to learn more!
Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.
Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.